In summary, considering the indicated role for a Th1 inflammatory profile in the development of TAAs, the Th2 shift associated with T2D, potentially contributed to by elevated plasma levels of the gut hormone GLP-1, may play a role in the reduced prevalence of TAAs in patients with T2D. The gene discussed is GCG; the disease is type 2 diabetes mellitus.